CXCL12 and neoplasm: CD36 also exhibited positive correlations with several immunostimulators, including C10orf54, CXCL12, ENTPD1, CD28, and TNFSF18, suggesting that it may contribute to immune activation pathways and modulation of antitumor immune responses in the tumor microenvironment (Fig. S4D).